Upper Tract Urothelial Cancer (UTUC) Guidelines – An Interactive and Evidence-Based Course Highlighting the Full Spectrum of Disease via Case Discussion and Video Presentation Webcast (2024)

This course will draw from the newly developed AUA Guidelines for Upper Tract Urothelial Cancer to provide an interactive, case-based approach for management of complex cases with attendee involvement to enhance their knowledge of this challenging disease and provide a basis for practice improvement. Aspects such as optimizing initial workup and risk stratification, endoscopic techniques for biopsy and treatment, multidisciplinary management (e.g., coordinating with medical oncology, nephrology, genetic counseling) and surgical approaches will be stressed. Presentations will include video demonstrations of surgical techniques for endoscopic, robotic and open approaches. New/emerging therapies and technologies such as topical and laser-based treatments will be covered including management of complications and follow-up strategies. 


This educational activity is supported by independent educational grants from:

Merck & Co., Inc.

Learning Objectives

At the conclusion of this activity, participants will be able to:

  1. Identify demographics, predisposing risks, hereditary factors, common terms.
  2. Describe workup, imaging, role of standardized endoscopic assessment, cytology and biopsy.
  3. Apply clinical features of disease risk, role of risk assessment and management options.
  4. Identify candidates for endo management, describe counseling/risks, safe approaches, troubleshooting.
  5. Explain setting and role for adjunctive chemotherapy use, importance of renal function, genetic counseling; describe approach to ureterectomy/bladder cuff, node dissection templates, intravesical therapy use; explain the rationale and use of risk-adjusted follow-up for endoscopy and imaging.
Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Non-Physician Participation
Course opens: 
Course expires: 


NameCompany NameRelationship TypeEnd Date
Baker, MariaGuardant HealthInvestment InterestCurrent
Baker, MariaExact SciencesInvestment InterestCurrent
Baker, MariaNeoGenomicsInvestment Interest08/14/2023
Baker, MariaIlluminaInvestment Interest07/10/2023
Baker, Maria23andMeInvestment Interest07/10/2023
Coleman, Jonathan AndrewNo relevant financial relationships to disclose
Raman, Jay D.No relevant financial relationships to disclose
Simon, NicholasNo relevant financial relationships to disclose
Truong, HongNo relevant financial relationships to disclose



PDF iconEducation Council Disclosures


PDF iconCOI Review Work Group Disclosures

AUA Office of Education Staff has nothing to disclose.

All relevant financial relationships have been mitigated.

Method of Participation: Learners will participate in this online educational activity by viewing the webcast and completing the post-test and evaluation. To claim CME credit for this enduring material, learners must complete the post-test, passing with 80% accuracy, and submit the program evaluation.

Release Date: May, 2024
Expiration Date: May, 2025

Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation: The American Urological Association designates this enduring material for a maximum of 2 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

Evidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider all financial relationships with any commercial interest (aka ineligible company) during the previous 24 months. The AUA must determine if the individual’s relationships may influence the educational content and mitigate any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Mitigation of Identified Conflict of Interest: All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group Chair and/or Vice Chair for identification of conflicts of interest. The AUA COI Review Work Group, working with Office of Education staff, will document the mechanism(s) for management and mitigation of the conflict of interest and final approval of the activity will be documented prior to implementation. 

Off-label or Unapproved Use of Drugs or Devices: The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.


Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.

Available Credit

  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Non-Physician Participation
Please login or register to take this course.